Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toremifene Chemoprevention in High-Risk Breast Cancer Population in China
ChiCTR2000037420Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in breast cancer and breast lesion comparing Toremifene with Placebo (2 arms). Primary endpoint: Incidence rate of breast cancer and precancerous breast lesions. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
toremifene
03
Conditions
breast cancerbreast lesion
Beyond the preview
Go deeper on ChiCTR2000037420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037420.